MMP9 and lung carcinoma: Similarly, MIA-690 counteracted IR-induced phosphorylation of STAT3 and NF-κB, which, in lung cancer, has been linked to the upregulation of COX-2, MMP9, and cyclin D1, factors that contribute to increased cancer cell survival, proliferation, invasion, and EMT [51,52].